April 8, 2022
Kowa appealed to the Intellectual Property High Court on April 6 in a lawsuit it had filed against Towa Pharmaceutical claiming that the generic manufacturer’s version of the hyperlipidemia treatment Livalo (pitavastatin) OD tablets infringe its patent rights. The Tokyo...read more